Q4 2024 · 13F-HR
Data Collective IV GP, LLCholdings as filed
Filed 2025-02-14 · accession 0001104659-25-013451
$226.3M
Reported value
6
Positions
2024-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 02156V109 | OKLO | Oklo Inc. | $112.0M | 49.5% | 5,277,513 | Common | SOLE |
| 75629V104 | RXRX | Recursion Pharmaceuticals, Inc. | $40.2M | 17.7% | 5,941,120 | Common | SOLE |
| 30049H102 | EVLV | Evolv Technologies Holdings, Inc. | $38.2M | 16.9% | 9,681,281 | Common | SOLE |
| 773122106 | — | Rocket Lab USA, Inc. | $35.1M | 15.5% | 1,377,943 | Common | SOLE |
| 60255C885 | BRD1EUR | Mind Medicine (MindMed) Inc. | $698,436 | 0.31% | 100,350 | Common | SOLE |
| G76279101 | ROIV | Roivant Sciences Ltd. | $45,841 | 0.02% | 3,875 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.